Virtual reality brain training from home may slow Alzheimer's — study investigates
NCT ID NCT07722169
First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time
Summary
This trial tests whether home-based virtual reality cognitive exercises, done on a tablet, can help slow mental decline in people with mild-to-moderate Alzheimer's disease. Some participants will also have online sessions with a neuropsychologist. The study aims to find a practical, validated way to deliver cognitive training remotely, potentially easing the burden on caregivers and the healthcare system.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- home-based virtual reality cognitive training using VRRS tablets, with or without online cognitive telerehabilitation sessions supervised by a neuropsychologist
- What this could lead to
- If effective, this approach could offer a validated, scalable way to slow cognitive decline in Alzheimer's disease while reducing caregiver burden and healthcare costs.
- What could go wrong
- This is a small, early-stage study (48 participants) testing a non-drug intervention, so results may not generalize. The benefit may be modest, and adherence to home training could be challenging.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.